Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase II, observer blind, randomized, multi center study to evaluate the safety and immunogenicity of two 0.25 ml or 0.5 ml doses of investigational vaccine and active influenza vaccine in healthy children aged 6 to less than 60 months

Next Previous
Trial Profile

A phase II, observer blind, randomized, multi center study to evaluate the safety and immunogenicity of two 0.25 ml or 0.5 ml doses of investigational vaccine and active influenza vaccine in healthy children aged 6 to less than 60 months

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 11 Nov 2019

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 13 Jan 2010 Patient numbers amended from 326 to 360 as reported by ClinicalTrials.gov.
  • 23 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
  • 16 Apr 2008 New trial record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top